Effects of H2-antagonists on androgen imprinting of male hepatic functions.

Many of the sex-differentiated functions of the liver of adult male rats depend upon the occurrence of neonatal androgen imprinting, a brief surge of androgen early in life. We investigated whether androgen imprinting is necessary for the development and maintenance of levels of a microsomal enzyme, estrogen-2-hydroxylase (E-20Hase), and a male-specific cytosolic estrogen binder (MEB) which are higher in adult male than in adult female rats. Cimetidine, a weakly antiandrogenic H2 blocker, was administered to pregnant and lactating rats from day 12 of gestation through weaning on day 21. Livers of male progeny, 120-150 days of age, were assayed for E-2OHase and MEB activity; a maternal dose equivalent to 2.5 times the usual human dose inhibited MEB activity in the levels of the offspring by 40% but had no effect on E-2OHase. However, a higher dose (5 times the human dose) was effective in reducing the E-2OHase activity by 50%. Rats whose mothers had received either no drug or an equivalent dose of ranitidine, another H2 blocker without antiandrogenic activity, were used as controls. The groups were not different in hepatic cytosolic androgen receptor content, body weight, or serum testosterone. In other studies, the requirement of neonatal androgen imprinting for full expression of adult levels of MEB and E-2OHase was determined. Female rats, which have low levels of E-2OHase and undetectable levels of MEB, were given androgen on day 1, on day 60 after ovariectomy, or at both times. Levels of E-2OHase equivalent to those in adult males were induced in females receiving both androgen treatments, whereas either treatment alone induced E-2OHase to the level of that in males castrated at adulthood or neonatally, which is about 50% that in normal male controls. In addition, MEB levels were induced in females to 85% of that in normal males by both androgen treatments and to 50% by administration of androgen to adult females or to adult males castrated neonatally. Administration of androgen to females during the neonatal period only did not induce MEB. We conclude that both MEB and E-2OHase require androgen imprinting for full expression in adult male rats.

[1]  F. Naftolin,et al.  H2-receptor antagonists and sexual differentiation. , 1984, Gastroenterology.

[2]  R. Palmiter,et al.  Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver , 1984, Cell.

[3]  D. V. van Thiel,et al.  Prenatal and neonatal exposure of male rat pups to cimetidine but not ranitidine adversely affects subsequent adult sexual functioning. , 1984, Gastroenterology.

[4]  G. Lucier,et al.  Imprinting of hepatic estrogen-binding proteins by neonatal androgens. , 1983, Endocrinology.

[5]  J. Gustafsson,et al.  Sex steroid induced changes in hepatic enzymes. , 1983, Annual review of physiology.

[6]  J. Dundee,et al.  Cimetidine as an oral antacid before elective Caesarean section , 1982, Anaesthesia.

[7]  D. V. van Thiel,et al.  Alcohol-induced changes in hepatic estrogen-binding proteins: a mechanism explaining feminization in alcoholics. , 1981, Archives of biochemistry and biophysics.

[8]  J. Dundee,et al.  The placental transfer of cimetidine , 1981, Anaesthesia.

[9]  F. Naftolin,et al.  Sexual differentiation of the central nervous system. , 1981, Science.

[10]  C. Bardin,et al.  Testosterone: a major determinant of extragenital sexual dimorphism. , 1981, Science.

[11]  D. V. van Thiel,et al.  Effect of ethanol feeding upon levels of a male-specific hepatic estrogen-binding protein: a possible mechanism for feminization. , 1981, Alcoholism, clinical and experimental research.

[12]  E. Mills,et al.  Interaction of H2-receptor antagonists with drug-metabolizing enzymes. , 1981, Biochemical Society transactions.

[13]  M. Daly,et al.  RANITIDINE: AN IMPROVED H2‐RECEPTOR ANTAGONIST FOR THE TREATMENT OF PEPTIC ULCER , 1980 .

[14]  S. Paul,et al.  The enzymatic formation of catecholestrogens from 2-methoxyestrogens by rat liver microsomes. , 1980, Endocrinology.

[15]  R. Palahniuk,et al.  Cimetidine premedication in elective caesarean section , 1980, Canadian Anaesthetists' Society journal.

[16]  H. T. Davenport,et al.  PROPHYLAXIS FOR MENDELSON'S SYNDROME BEFORE ELECTIVE CAESAREAN SECTION. A COMPARISON OF CIMETIDINE AND MAGNESIUM TRISILICATE MIXTURE REGIMENS , 1980, British journal of obstetrics and gynaecology.

[17]  D. V. van Thiel,et al.  Estrogen-binding proteins of male rat liver: influences of hormonal changes. , 1980, Archives of biochemistry and biophysics.

[18]  T. Hökfelt,et al.  CHAPTER 2 – The Hypothalamo–Pituitary–Liver Axis: A New Hormonal System in Control of Hepatic Steroid and Drug Metabolism , 1980 .

[19]  S. Paul,et al.  Estrogen-2-hydroxylase in the rat. Distribution and response to hormonal manipulation. , 1980, Biochemical Pharmacology.

[20]  W. Mcgowan.  Safety of Cimetidine in Obstetric Patients 1 , 1979, Journal of the Royal Society of Medicine.

[21]  D. V. van Thiel,et al.  Alcohol-induced testicular atrophy in the adult male rat. , 1979, Endocrinology.

[22]  O. Pelkonen,et al.  Cimetidine inhibits microsomal drug metabolism in the rat. , 1979, European journal of pharmacology.

[23]  D. Loriaux,et al.  Cimetidine is an antiandrogen in the rat. , 1979, Gastroenterology.

[24]  J W Funder,et al.  Cimetidine, a histamine H2 receptor antagonist, occupies androgen receptors. , 1979, Journal of Clinical Endocrinology and Metabolism.

[25]  S. Paul,et al.  Catechol estrogen-forming enzyme of brain: demonstration of a cytochrome p450 monooxygenase. , 1977, Endocrinology.

[26]  E. Horning,et al.  Sex differences in human urinary steroid metabolic profiles determined by gas chromatography. , 1977, Analytical biochemistry.

[27]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[28]  F. C. Goble.  Sex as a factor in metabolism, toxicity, and efficacy of pharmacodynamic and chemotherapeutic agents. , 1975, Advances in pharmacology and chemotherapy.

[29]  J. Gustafsson,et al.  Irreversible Androgenic Programming at Birth of Microsomal and Soluble Rat Liver Enzymes Active on 4-Androstene-3,17-dione and 5α-Androstane-3α,17β-diol , 1974 .

[30]  R. Kato,et al.  Sex-related differences in drug metabolism. , 1974, Drug metabolism reviews.

[31]  J. Gustafsson,et al.  Neonatal imprinting of liver microsomal hydroxylation and reduction of steroids. , 1973, The Journal of biological chemistry.

[32]  J. Daly,et al.  Catechol-O-methyltransferase. II. A new class of inhibitors of catechol-o-methyltransferase; 3,5-dihydroxy-4-methoxybenzoic acid and related compounds. , 1970, The Journal of pharmacology and experimental therapeutics.

[33]  J. Axelrod,et al.  Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.

[34]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .